Get the Stockscreener App
17.50
2.13%
-0.38
After Hours:
17.53
0.03
+0.17%
Clearpoint Neuro Inc stock is traded at $17.50, with a volume of 365.67K.
It is down -2.13% in the last 24 hours and up +27.27% over the past month.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
See More
Previous Close:
$17.88
Open:
$17.92
24h Volume:
365.67K
Relative Volume:
0.52
Market Cap:
$524.82M
Revenue:
$40.61M
Net Income/Loss:
$-29.07M
P/E Ratio:
-17.36
EPS:
-1.0081
Net Cash Flow:
$-26.70M
1W Performance:
-6.52%
1M Performance:
+27.27%
6M Performance:
+17.29%
1Y Performance:
+46.32%
1-Day Range:
$17.05
$17.92
1-Week Range:
$16.82
$18.90
52-Week Range:
$8.27
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Name
Clearpoint Neuro Inc
Sector
Industry
Phone
(949) 900-6833
Address
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
17.50 | 524.82M | 40.61M | -29.07M | -26.70M | -1.0081 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Oct-24-23 | Initiated | Stifel | Buy |
| Feb-16-23 | Resumed | B. Riley Securities | Buy |
| Apr-05-22 | Resumed | B. Riley Securities | Buy |
| Mar-18-21 | Initiated | Lake Street | Buy |
| Jul-17-20 | Initiated | B. Riley FBR | Buy |
View All
Clearpoint Neuro Inc Stock (CLPT) Latest News
(CLPT) Risk Channels and Responsive Allocation - Stock Traders Daily
ClearPoint Neuro (CLPT) surges 26.0%: Is this an indication of further gains? - MSN
Form 4 Clearpoint Neuro Inc For: 6 July By Investing.com - Investing.com Canada
Director at ClearPoint Neuro (NASDAQ: CLPT) receives 222-share stock grant - Stock Titan
ClearPoint Neuro (CLPT) Holds Steady Near $18.72 as Traders Eye Key Support and Resistance LevelsLong Term Entry Picks - dars.gov.et
CLPTClearPoint Neuro Inc Volatility & Greeks - Finviz
ClearPoint Neuro outlines growth ambitions in precision neurosurgery - ad-hoc-news.de
Form 4 Clearpoint Neuro Inc For: 2 July By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) CBO adds 1,781 ESPP shares, now holds 110,263 - Stock Titan
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer STIGALL L. JEREMY - Moomoo
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer D'Alessandro Danilo - Moomoo
ClearPoint Neuro (CLPT) CFO acquires 1,085 shares through ESPP - Stock Titan
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer BURNETT JOSEPH - Moomoo
Clearpoint Neuro Insider Sold Shares Worth $387,600, According to a Recent SEC Filing - marketscreener.com
ClearPoint Neuro CEO Burnett sells $387,600 in company shares By Investing.com - Investing.com Nigeria
ClearPoint Neuro CEO Burnett sells $387,600 in company shares - Investing.com
Form 4 Clearpoint Neuro Inc For: 1 July By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) CEO exercises options and sells 20,000 shares under 10b5-1 plan - Stock Titan
Price to sales forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Price to book forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Price to earnings forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Enterprise value to EBITDA forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
(CLPT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Director sale notice, CLPT (NASDAQ: CLPT) — 20,000 shares via option exercise - Stock Titan
ClearPoint Neuro | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Enterprise value to EBIT forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Enterprise value to revenue forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
ClearPoint Neuro, Inc. Actuals & Estimates (NASDAQ:CLPT) - TradingView
CLPT Forecast — Price Target — Prediction for 2027 - TradingView
Compared to estimates, ClearPoint Neuro (CLPT) Q1 earnings: A look at key metrics - MSN
ClearPoint Neuro, Inc. (CLPT) reports Q1 loss, lags revenue estimates - MSN
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Announces Target Price $30 - Moomoo
ClearPoint Neuro (CLPT) Surges 8.6% as Bullish Momentum BuildsTriple Top - dars.gov.et
Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), uniQure (QURE) - The Globe and Mail
ClearPoint Neuro (CLPT) CEO sells 61,843 shares after exercising options - Stock Titan
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating - Moomoo
Stifel Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $25 - Moomoo
Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), Tyra Bioscience (TYRA) - The Globe and Mail
Liquidity Mapping Around (CLPT) Price Events - Stock Traders Daily
CLPT Maintained by B. Riley Securities -- Price Target Raised to $30 - GuruFocus
ClearPoint Neuro Is Maintained at Buy by B. Riley Securities - Moomoo
B. Riley Securities Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $30 - Moomoo
Clearpoint Neuro Inc (CLPT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ClearPoint Neuro: AMT-130's FDA Reversal Revives The Bull Case (NASDAQ:CLPT) - Seeking Alpha
B. Riley Adjusts ClearPoint Neuro Price Target to $30 From $20, Maintains Buy Rating - marketscreener.com
ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains? - Yahoo Finance
Clearpoint Neuro Inc (CLPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Analysts Offer Insights on Healthcare Companies: Verastem (VSTM) and ClearPoint Neuro (CLPT) - The Globe and Mail
Clearpoint Neuro Inc (CLPT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Clearpoint Neuro Inc (CLPT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Clearpoint Neuro Inc (CLPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Clearpoint Neuro Inc Stock (CLPT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):